ICCM News and Press, IceCure Medical Ltd. From 10/05/23

2023-10-05 10:10:30 ET DENVER, Colo., Oct 5, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; IceCure Medical Ltd. (NASDAQ: ICCM), VS Media Holdings (NASDAQ: VSME), Vivos Therapeutics (NASDAQ: VVOS), Femas...

Women Deemed Inoperable for Breast Cancer Benefitted from IceCure Medical's ProSense as an Independent Study Performed in Italy Showed a Tumor Reduction Rate of 93.43% to 96.81% PR Newswire Disappearance of lesions and absence of residual malignant cells in Luminal-A ...

2023-10-02 12:50:19 ET DENVER, Colo., Oct 2, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; Icecure Medical Ltd (NASDAQ: ICCM), Femasys (NASDAQ: FEMY), AERWINS Technologies (NASDAQ: AWIN), Momentu...

2023-10-02 10:04:07 ET DENVER, Colo., Oct 2, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; Icecure Medical Ltd (NASDAQ: ICCM), Femasys (NASDAQ: FEMY), AERWINS Technologies (NASDAQ: AWIN), Invitae (NYSE:...

2023-10-02 09:19:31 ET More on IceCure Medical IceCure Medical Ltd (ICCM) Q2 2023 Earnings Call Transcript IceCure Medical shares plunge 40% on FDA update IceCure Medical's ProSense System for tumor treatment receives regulatory nod in Brazil Seeking Alpha&#x...

2023-10-02 08:31:38 ET (24/7 MARKET NEWS) – IceCure Medical Ltd. (NASDAQ: ICCM) stated, this morning, that new data, from a study that was conducted in Spain with women who declined standard of care surgery, was presented at the European Society of Breast Imaging (“EUSOBI ...

Independent Study Validates IceCure's ProSense Cryoablation is Safe & Effective Outpatient Procedure for Breast Cancer with 96.8% Success Rate Independent Study Validates IceCure's ProSense Cryoablation is Safe & Effective Outpatient Procedure for Breast Cancer with 96.8% Succes...

Renowned Spanish Radiologist Lucía Graña-López to Present Data Using IceCure Medical's ProSense at European Society of Breast Imaging Scientific Meeting 2023 PR Newswire Growing body of evidence-based data is giving women a minimally invasive alternative to ...

2023-09-20 12:10:04 ET More on IceCure Medical Seeking Alpha’s Quant Rating on IceCure Medical Historical earnings data for IceCure Medical Financial information for IceCure Medical IceCure Medical Ltd (ICCM) Q2 2023 Earnings Call Transcript Ic...

IceCure Medical Receives FDA Response to De Novo Classification Request for Breast Cancer PR Newswire CAESAREA, Israel , Sept. 20, 2023 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM), developer of the ProSense® System, a minimally-invasive cryoablat...